Botulinum toxin provides symptomatic relief for patients with Type 3 Sphincter of Oddi dysfunction

Jonathan Evans  1     Hannah Gordon  1     Colin Ainley  1    
1 Royal London Hospital,London,United Kingdom

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing